7511-46-8

Basic information

• Product Name: 3-(4-methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid
• CAS NO: 7511-46-8
• Molecular Formula: C₇H₁₀N₂O₄
• Molecular Weight: 186.1653
• Mol File: 7511-46-8.mol
• Article Data: 3

Chemical Properties

• Density: 1.321g/cm³
• Refractive Index: 1.492
• CAS DataBase Reference: 3-(4-methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid(7511-46-8)
• EPA Substance Registry System: 3-(4-methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid(7511-46-8)

Safety Data

• Hazardous Substances Data: 7511-46-8(Hazardous Substances Data)

Usage

Description

3-(4-methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid is a chemical compound with the molecular formula C7H9NO5. It is a derivative of imidazolidine and belongs to the class of organic compounds known as ureas. 3-(4-methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid is often used in pharmaceutical research and development due to its potential applications in treating various medical conditions.

Uses

Used in Pharmaceutical Research and Development:
3-(4-methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid is used as a research compound for exploring its potential applications in the treatment of various medical conditions. Its precise mechanism of action and specific uses are still being studied, making it a valuable asset in the development of new pharmaceuticals.

Upstream product

• 43189-49-7 racemic 3-(4-methyl-2,5-dioxoimidazolidin-4-yl)propionic acid 
• 123-76-2 levulinic acid 

Relevant articles and documents

5-[3-[PIPERIDIN-1-YL]-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS 4 AND 5 INHIBITORS FOR TREATING E.G. OSTEOARTHRITIS

The present invention discloses 5-[3-[piperazin-l-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives according to Formula (I), wherein R1, R2, R3a, R3b, R6a, R6b, the subscript n and Cy are as defined herein. The present invention relates to compounds inhibiting ADAMTS 4 and 5 for the prophylaxis or treatment of inflammatory diseases or diseases involving degradation of cartilage or disruption of cartilage homeostasis, such as e.g. osteoarthritis.

5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS

The present invention discloses compounds according to Formula (I), wherein R, R2, R3a, R3b, and Cy are as defined herein. The present invention discloses compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same and methods for the prophylaxis and/or treatment of inflammatory conditions and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis.